Xcout IntelOxford BioTherapeutics competitors & alternatives
The 12 closest competitors and alternatives to Oxford BioTherapeutics among biotech companies — ranked by similarity to what Oxford BioTherapeutics actually does, not by market-cap band.
Subscribe to see Oxford BioTherapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Oxford BioTherapeutics
Oxford BioTherapeutics is a clinical-stage oncology company focused on developing first-in-class cancer therapeutics with a proprietary pipeline. The company operates from locations in Oxford, United Kingdom, as well as San Jose, California, and Morristown, New Jersey, in the United States.
Oxford BioTherapeutics at a glance
Oxford BioTherapeutics is a biotech company headquartered in United Kingdom, founded in 2004. Xcout tracks 14 named people at Oxford BioTherapeutics, including Christian Rohlff (Chief Executive Officer, Oxford). Xcout recorded 2 job postings from Oxford BioTherapeutics in the last 90 days.
Oxford BioTherapeutics leadership
- Christian RohlffChief Executive Officer, Oxford
- Harald HaeskeChief Medical Officer, Oxford
- Benjamin ThomasSVP Operations, Oxford
- Martin BarnesSVP Bioinformatics and Information Systems, Oxford
- Andrew DickinsonVP of Clinical Operations, Oxford
- Matthew MetzgerVice President, US Operations
8 more named people on record for Oxford BioTherapeutics, with roles, board committees and tenure — see the full roster →
Hiring at Oxford BioTherapeutics
Xcout recorded 2 job postings from Oxford BioTherapeutics in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Oxford BioTherapeutics's hiring signals →
Top 12 Oxford BioTherapeutics competitors
Ranked by semantic similarity — how close each company is to Oxford BioTherapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Dark Blue Therapeutics is an innovative drug discovery biotechnology company based in Oxford, United Kingdom, focused on early oncology research before being acquired by Amgen.
Biotechnology
Aadi Bioscience, Inc. is a commercial-stage biopharmaceutical company headquartered in Morristown, New Jersey, focused on developing precision therapies for genetically defined cancers.
Biotechnology
Grey Wolf Therapeutics is a biotechnology company headquartered in the UK focused on delivering a new class of treatments to improve the lives of people with cancers and autoimmune disorders.
Similar biotech company
Oncolytics Biotech Inc. is a clinical-stage biotechnology company developing pelareorep, an investigational intravenously administered therapeutic. The company focuses on unleashing the power of the immune system and operates as a public company with a small team based in San Diego, California.
Biotechnology
Orbus Therapeutics, Inc. is a pharmaceutical company headquartered in Menlo Park, California, dedicated to developing treatments for rare forms of cancer, including clinical trials for brain tumors.
Biotechnology
Revolution Medicines is a clinical-stage oncology company that develops novel targeted therapies to outsmart cancer. The company focuses on discovering and advancing therapeutic pipelines for patients with difficult-to-treat tumors.
Biotechnology
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Similar biotech company
Scancell Holdings plc is a clinical-stage biopharmaceutical firm focused on discovering and developing innovative vaccine and antibody treatments. Its mission is to address significant unmet medical needs in both cancer and infectious diseases. The company's pipeline features several promising candidates, including SCIB1, currently in Phase II clinical trials for metastatic melanoma; SCIB2, aimed at non-small cell lung cancer; and Modi-1, which is undergoing Phase I/II studies for various indications such as head and neck, triple-negative breast, ovarian, and renal cancers. Additionally, Scancell is advancing Modi-2, a therapeutic agent specifically designed to target homocitrullinated cancer antigens. Its development efforts also encompass SCOV1 and SCOV2 COVIDITY, a prophylactic DNA vaccine engineered to provide protection against the SARS-CoV-2 virus. Founded in 1997, Scancell Holdings plc is headquartered in Oxford, United Kingdom.
Life Sciences
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Biotechnology
BioEclipse Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in California. The company is focused on researching and developing a novel generation of targeted immunotherapies and treatments for oncology.
Biotechnology
Artios Pharma is an independent biotechnology company headquartered at the Babraham Research Campus in Cambridge, United Kingdom, focused on discovering novel cancer therapies through DNA damage response mechanisms.
Similar biotech company
OSE Immunotherapeutics is a clinical-stage biotechnology company that develops innovative immunotherapies for immune activation and regulation in immuno-oncology and immuno-inflammation. The company utilizes proprietary research platforms and a portfolio of clinical-stage assets to provide therapeutic options for patients.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Oxford BioTherapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Oxford BioTherapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →